Peter V. Sguigna

Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8

Youngah Jo, Peter Chang-Whan Lee, Peter V. Sguigna et al. · Proceedings of the National Academy of Sciences · 2011 · 160 citations · Full text

Membrane-associated Ubiquitin Ligase Complex Containing gp78 Mediates Sterol-accelerated Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase

Youngah Jo, Peter V. Sguigna, Russell A. DeBose‐Boyd · Journal of Biological Chemistry · 2011 · 94 citations · Full text

Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations

Ram Narayan, Cynthia Wang, Peter V. Sguigna et al. · Multiple Sclerosis and Related Disorders · 2018 · 61 citations

Pathology, Neurology, Atypical Anti-mog Syndrome +2

Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials

Jimin Ren, Richard B. Dewey, Austin Rynders et al. · Journal of Nanobiotechnology · 2023 · 38 citations · Full text

Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics

Ethan Meltzer, Peter V. Sguigna, Adnan Subei et al. · JAMA Neurology · 2017 · 33 citations · Full text